Melanoma Research Today is a free monthly online journal that collates and summarizes the latest research about Melanoma, including details on identification, causes, prevention, treatment.

Volume 3 (2006), Issue 10 (October)

1. Bilateral diffuse melanocytic proliferation associated with ovarian carcinoma and metastatic malignant amelanotic melanoma.
   Am J Ophthalmol, 142(4): 693-5. [Abstract] [Full-text]
2. The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study.
   Br J Cancer, 95(7): 829-34. [Abstract] [Full-text]
3. Cancer regression in patients after transfer of genetically engineered lymphocytes.
   Science, 314(5796): 126-9. [Abstract] [Full-text]
4. Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.
   J Clin Oncol, 24(29): 4738-45. [Abstract] [Full-text]
5. Pectic polysaccharide isolated from Angelica gigas Nakai inhibits melanoma cell metastasis and growth by directly preventing cell adhesion and activating host immune functions.
   Cancer Lett, 243(2): 264-73. [Abstract] [Full-text]
6. Vascular endothelial growth factor a in eyes with uveal melanoma.
   Arch Ophthalmol, 124(10): 1428-34. [Abstract] [Full-text]
7. A novel type of deletion in the CDKN2A gene identified in a melanoma-prone family.
   Genes Chromosomes Cancer, 45(12): 1155-63. [Abstract] [Full-text]
8. Enhanced metastatic dissemination to multiple organs by melanoma and lymphoma cells in timp-3-/- mice.
   Oncogene, 25(49): 6489-96. [Abstract] [Full-text]
9. Malignant mucosal melanoma of the right maxillary sinus: a case report.
   Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 102(5): e20-2. [Abstract] [Full-text]
10. Melanoma chemoprevention.
    J Am Acad Dermatol, 55(5): 849-61. [Abstract] [Full-text]
11. Prognostic significance of extent of ulceration in primary cutaneous melanoma.
    Am J Surg Pathol, 30(11): 1396-400. [Abstract] [Full-text]
12. MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk.
    Int J Cancer, 119(11): 2597-602. [Abstract] [Full-text]
13. Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma.
    J Clin Oncol, 24(31): 5060-9. [Abstract] [Full-text]

© 2004-2008 Melanoma Research Today. All Rights Reserved.